Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Lincoln Pharmaceuticals Ltd
Total Liabilities & Equity
Lincoln Pharmaceuticals Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
|
Total Liabilities & Equity
₹7.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Liabilities & Equity
₹467.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Liabilities & Equity
₹346.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Liabilities & Equity
₹881.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Liabilities & Equity
₹150.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Total Liabilities & Equity
₹119.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lincoln Pharmaceuticals Ltd
Glance View
Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm offers products, such as tablets, capsules, liquid injection, cream in tubes, dry power injection, liquid in bott, liquid injection and pharma products. The company has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The firm serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The firm's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.
See Also
What is Lincoln Pharmaceuticals Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
7.8B
INR
Based on the financial report for Dec 31, 2024, Lincoln Pharmaceuticals Ltd's Total Liabilities & Equity amounts to 7.8B INR.
What is Lincoln Pharmaceuticals Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
11%
Over the last year, the Total Liabilities & Equity growth was 18%. The average annual Total Liabilities & Equity growth rates for Lincoln Pharmaceuticals Ltd have been 14% over the past three years , 13% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet